Studies Of Hereditary Neurological Disease: Clinical Trials
$200,608ZIAFY2022NSNIH
National Institute Of Neurological Disorders And Stroke
Investigators
Linked publications, trials & patents
Paper 36072267Paper 35741698Paper 31059640Paper 30337273Paper 29478602Paper 28904987Paper 28877556Paper 28601553Paper 27593185Paper 26515625Paper 26273686Paper 25913211Paper 25307854Paper 24876969Paper 24794818Paper 23678877Paper 23656576Paper 23408598Paper 23239403Paper 22668795Paper 21216197Paper 21035368Paper 20863580Paper 20808230Paper 20599042Paper 20090835Paper 19846582Paper 19670325Paper 19283350Paper 19259961Paper 17826341Paper 17562928
Abstract
The purpose of this research program is to develop safe and effective treatments for hereditary neurological disorders. We recently reported improvement with functional exercise in a patient with spinal and bulbar muscular atrophy (SBMA). Natural history studies are currently underway for SBMA and ALS4, an early-onset hereditary motor neuron disease caused by mutations in senataxin, and one or more interventional studies for SBMA are under consideration for next year. The interventional studies will be designed based on muscle function and muscle imaging data collected in our SBMA natural history study and previous clinical studies by our group and others.
View original record on NIH RePORTER →